Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant FOLFOXIRI in Locally Advanced Rectal Cancer
NCT02217020Phase 2Completed
- Sponsor
- Sun Yat-sen University
- Start
- Aug 2014
- Primary completion
- Sep 2016
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of fluorouracil, oxaliplatin, irinotecan in rectal cancer, sponsored by Sun Yat-sen University. Started Aug 2014; status: completed.
02
Drugs
fluorouraciloxaliplatinirinotecan
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT02217020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02217020.